Eli Lilly agreed to acquire AtaiBeckley for up to $3.8 billion—of which Lilly will pay $2.8 billion upfront. The deal, set to ...
Warsh is reluctant to signal future interest rate moves — how will the hedge funds that own US Treasuries react?